SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-022322
Filing Date
2022-11-07
Accepted
2022-11-07 07:31:12
Documents
90
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q beam-20220930.htm   iXBRL 10-Q 3762439
2 EX-31.1 beam-ex31_1.htm EX-31.1 23028
3 EX-31.2 beam-ex31_2.htm EX-31.2 23184
4 EX-32.1 beam-ex32_1.htm EX-32.1 13541
5 EX-32.2 beam-ex32_2.htm EX-32.2 13570
  Complete submission text file 0000950170-22-022322.txt   14010047

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT beam-20220930_pre.xml EX-101.PRE 512971
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT beam-20220930.xsd EX-101.SCH 78239
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT beam-20220930_lab.xml EX-101.LAB 585341
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT beam-20220930_cal.xml EX-101.CAL 66485
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT beam-20220930_def.xml EX-101.DEF 332644
84 EXTRACTED XBRL INSTANCE DOCUMENT beam-20220930_htm.xml XML 3114600
Mailing Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 857-327-8775
Beam Therapeutics Inc. (Filer) CIK: 0001745999 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39208 | Film No.: 221363732
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences